Kimberly A. Bertrand, ScD
Associate Professor
Boston University Chobanian & Avedisian School of Medicine
Medicine
Preventive Medicine & Epidemiology

ScD, Harvard School of Public Health
MPH, Boston University School of Public Health
BS, Brown University

Pronouns: she/her/hers



Dr. Bertrand’s research focuses primarily on the epidemiology of cancer, with an emphasis on understanding racial disparities in incidence and outcomes. She is currently Multiple Principal Investigator of the Black Women’s Health Study (BWHS), a prospective cohort study of over 59,000 self-identified Black women begun in 1995. Dr. Bertrand is actively involved in several epidemiologic studies to evaluate risk factors for high mammographic density, a strong independent predictor of breast cancer, and the role mammographic density and other risk factors may play in breast tumor aggressiveness in this and other populations. In addition, she leads research to identify factors that explain racial disparities in multiple myeloma.

Diversity, Equity, Inclusion and Accessibility

I am deeply committed to teaching and mentoring the next generation of research scientists and I am dedicated to developing a diverse scientific workforce and promoting an inclusive and supportive scientific and academic environment, where trainees from every background, including the most disadvantaged, can thrive. Many of my current and previous mentees have been from underrepresented minority groups. I am also a mentor for BUMC’s American Cancer Society Post-Baccalaureate Fellows Program (PI: Rachel Flynn), which aims to increase diversity in the cancer research workforce by increasing the number of underrepresented groups in Biomedical Science.

As a recognized leader in cancer disparities research, I was recently invited to serve on a panel to review R01 grant applications to the NCI Cancer Moonshot Scholars Diversity Program. I am also a mentor with NCI’s Early Investigator Advancement Program, which aims to facilitate the advancement of underrepresented scientists in cancer research. My commitment to these activities is influenced both by my scientific interest in reducing cancer disparities as well as my experiences in academia as a first-generation college graduate.

Associate Professor
Boston University Chobanian & Avedisian School of Medicine
Slone Epidemiology Center


Center Faculty Member
Boston University Chobanian & Avedisian School of Medicine
Slone Epidemiology Center


Member
Boston University
BU-BMC Cancer Center


Epidemiologist
Boston University Chobanian & Avedisian School of Medicine
Slone Epidemiology Center


Member
Boston University
Genome Science Institute




Geospatially modeled environmental risk factors for lymphoid malignancies
01/15/2024 - 10/31/2028 (Subcontract PI)
The Brigham and Women's Hospital, Inc. NIH NIEHS
1R01ES034079-01A1

A Follow-up Study for Causes of Cancer in Black Women
09/01/2022 - 08/31/2027 (Multi-PI)
PI: Kimberly A. Bertrand, ScD
NIH/National Cancer Institute
5U01CA164974-14

Advancing breast cancer risk prediction in national cohorts: the role of mammogram-based deep learning
09/21/2023 - 08/31/2026 (Subcontract PI)
Trustees Of Columbia University In The City Of New York NIH NCI
1U01CA276553-01A1

Determinants of the racial/ethnic disparity in MGUS risk: An epidemiologic study in 4 cohorts
09/20/2021 - 08/31/2026 (Subcontract PI)
University of California, Irvine NIH NCI
5R01CA260615-02

Socio-environmental context in monoclonal gammopathy of undetermined significance (MGUS) disparities
06/01/2021 - 05/31/2026 (PI)
NIH/National Cancer Institute
5R01CA249982-04

Comprehensive molecular characterization of endometrial cancer, etiologic heterogeneity, and racial disparities
02/05/2021 - 01/31/2026 (Subcontract PI)
The Brigham and Women's Hospital, Inc. NIH NCI
5U01CA250476-04

A prediction model to simultaneously estimate personal risk of breast cancer and death from other causes in women aged 55 and older
08/01/2020 - 04/30/2025 (Subcontract PI)
Beth Israel Deaconess Medical Center, Inc. NIH NCI
5R01CA242747-03

Assessment of industrial emissions in the Black Women's Health Study (BWHS) cohort
05/10/2024 - 09/24/2024 (Subcontract PI)
Westat, Inc. NIH NCI


Black Women's Health Study samples for a multi-ancestry genome-wide association study of lymphoid malignancies
08/30/2023 - 08/29/2024 (PI)
NIH/National Cancer Institute
75N91023P00774

Conducting a National Death Index search among three generations of DES-exposed and unexposed study participants
05/17/2022 - 11/30/2023 (Subcontract PI)
Westat, Inc. NIH NCI
75N91021C00012

Showing 10 of 12 results. Show All Results


Title


Yr Title Project-Sub Proj Pubs
2024 Advancing breast cancer risk prediction in national cohorts: the role of mammogram-based deep learning 5U01CA276553-02
2024 Determinants of the racial/ethnic disparity in MGUS risk: An epidemiologic study in 4 cohorts 5R01CA260615-04
2024 Socio-environmental context in monoclonal gammopathy of undetermined significance (MGUS) disparities 5R01CA249982-04
2024 A Follow-up Study for Causes of Cancer in Black Women 5U01CA164974-14
2023 Advancing breast cancer risk prediction in national cohorts: the role of mammogram-based deep learning 1U01CA276553-01A1
2023 Determinants of the racial/ethnic disparity in MGUS risk: An epidemiologic study in 4 cohorts 5R01CA260615-03
2023 Socio-environmental context in monoclonal gammopathy of undetermined significance (MGUS) disparities 5R01CA249982-03
2023 A Follow-up Study for Causes of Cancer in Black Women 5U01CA164974-13
2022 Socio-environmental context in monoclonal gammopathy of undetermined significance (MGUS) disparities 5R01CA249982-02
2021 Determinants of the racial/ethnic disparity in MGUS risk: An epidemiologic study in 4 cohorts 1R01CA260615-01
Showing 10 of 15 results. Show All Results

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

iCite Analysis       Copy PMIDs To Clipboard

  1. Abdallah M, Arters F, Patel J, Edwards CV, Lerner A, Petrocca F, Dockerty M, Fuller B, Godfrey A, Staron A, Sanchorawala V, Sloan JM, Bertrand KA, Szalat RE. Febrile Neutropenia in Patients with Duffy-null Associated Neutrophil Counts and Multiple Myeloma or AL amyloidosis. Blood Adv. 2024 Sep 30.View Related Profiles. PMID: 39348709
     
  2. Peeri NC, Bertrand KA, Na R, De Vivo I, Setiawan VW, Seshan VE, Alemany L, Chen Y, Clarke MA, Clendenen T, Cook LS, Costas L, Dal Maso L, Freudenheim JL, Friedenreich CM, Gierach GL, Goodman MT, La Vecchia C, Levi F, Lopez-Querol M, Lu L, Moysich KB, Mutter G, Naduparambil J, Negri E, O'Connell K, O'Mara T, Palmer JR, Parazzini F, Penney KL, Petruzella S, Reynolds P, Ricceri F, Risch H, Rohan TE, Sacerdote C, Sandin S, Shu XO, Stolzenberg-Solomon RZ, Webb PM, Wentzensen N, Wilkens LR, Xu W, Yu H, Zeleniuch-Jacquotte A, Zheng W, Guo X, Lipworth L, Du M. Understanding risk factors for endometrial cancer in young women. J Natl Cancer Inst. 2024 Sep 05.View Related Profiles. PMID: 39235934
     
  3. Bigham Z, Holder EX, Rodday AM, Breeze J, Nelson KP, Palmer JR, Freund KM, Bertrand KA. Lifecourse growth and development determinants of mammographic density in Black women. Cancer Epidemiol Biomarkers Prev. 2024 Aug 02.View Related Profiles. PMID: 39093038
     
  4. Titus L, Hatch EE, Bertrand KA, Palmer JR, Strohsnitter WC, Huo D, Curry M, Hyer M, Aagaard K, Gierach GL, Troisi R. Benign and Malignant Outcomes in the Offspring of Females Exposed In Utero to Diethylstilbestrol (DES): An Update from the NCI Third Generation Study. Cancers (Basel). 2024 Jul 18; 16(14).View Related Profiles. PMID: 39061214; PMCID: PMC11274475; DOI: 10.3390/cancers16142575;
     
  5. Habeshian TS, Peeri NC, De Vivo I, Schouten LJ, Shu XO, Cote ML, Bertrand KA, Chen Y, Clarke MA, Clendenen TV, Cook LS, Costas L, Dal Maso L, Freudenheim JL, Friedenreich CM, Gallagher G, Gierach GL, Goodman MT, Jordan SJ, La Vecchia C, Lacey JV, Levi F, Liao LM, Lipworth L, Lu L, Matias-Guiu X, Moysich KB, Mutter GL, Na R, Naduparambil J, Negri E, O'Connell K, O'Mara TA, Onieva Hernández I, Palmer JR, Parazzini F, Patel AV, Penney KL, Prizment AE, Ricceri F, Risch HA, Sacerdote C, Sandin S, Stolzenberg-Solomon RZ, van den Brandt PA, Webb PM, Wentzensen N, Wijayabahu AT, Wilkens LR, Xu W, Yu H, Zeleniuch-Jacquotte A, Zheng W, Du M, Setiawan VW. Hypertension and Risk of Endometrial Cancer: A Pooled Analysis in the Epidemiology of Endometrial Cancer Consortium (E2C2). Cancer Epidemiol Biomarkers Prev. 2024 Jun 03; 33(6):788-795.View Related Profiles. PMID: 38530242; PMCID: PMC11145161; DOI: 10.1158/1055-9965.EPI-23-1444;
     
  6. Troisi R, Bertrand K, Hatch EE, Strohsnitter WC, Aagaard K, Robboy SJ, Gierach G, Titus L. An Update on Prenatal Diethylstilbestrol Exposure and High-Grade Squamous Intraepithelial Lesions of the Lower Genital Tract. Obstet Gynecol. 2024 Apr 01; 143(4):603-606.View Related Profiles. PMID: 38422500; PMCID: PMC11059972; DOI: 10.1097/AOG.0000000000005547;
     
  7. Von Holle A, Adami HO, Baglietto L, Berrington de Gonzalez A, Bertrand KA, Blot W, Chen Y, DeHart JC, Dossus L, Eliassen AH, Fournier A, Garcia-Closas M, Giles G, Guevara M, Hankinson SE, Heath A, Jones ME, Joshu CE, Kaaks R, Kirsh VA, Kitahara CM, Koh WP, Linet MS, Park HL, Masala G, Mellemkjaer L, Milne RL, O'Brien KM, Palmer JR, Riboli E, Rohan TE, Shrubsole MJ, Sund M, Tamimi R, Tin Tin S, Visvanathan K, Vermeulen RC, Weiderpass E, Willett WC, Yuan JM, Zeleniuch-Jacquotte A, Nichols HB, Sandler DP, Swerdlow AJ, Schoemaker MJ, Weinberg CR. BMI and breast cancer risk around age at menopause. Cancer Epidemiol. 2024 Apr; 89:102545.View Related Profiles. PMID: 38377945; PMCID: PMC10942753; DOI: 10.1016/j.canep.2024.102545;
     
  8. Kataria Y, Niharika Pillalamarri B, Zirpoli G, Szalat R, Palmer JR, Bertrand KA. Body size and risk of multiple myeloma in the Black Women's Health Study. Br J Cancer. 2024 Mar; 130(5):830-835.View Related Profiles. PMID: 38212484; PMCID: PMC10912597; DOI: 10.1038/s41416-023-02571-w;
     
  9. Wolfson EA, Schonberg MA, Eliassen AH, Bertrand KA, Shvetsov YB, Rosner BA, Palmer JR, LaCroix AZ, Chlebowski RT, Nelson RA, Ngo LH. Validating a model for predicting breast cancer and nonbreast cancer death in women aged 55 years and older. J Natl Cancer Inst. 2024 Jan 10; 116(1):81-96.View Related Profiles. PMID: 37676833; PMCID: PMC10777669; DOI: 10.1093/jnci/djad188;
     
  10. Bertrand KA, Szalat R. Deciphering racial disparities in multiple myeloma outcomes. Blood Adv. 2024 Jan 09; 8(1):234-235.View Related Profiles. PMID: 38194241; PMCID: PMC10918417; DOI: 10.1182/bloodadvances.2023011457;
     
Showing 10 of 153 results. Show More

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Bar chart showing 152 publications over 15 distinct years, with a maximum of 20 publications in 2016

YearPublications
20107
20111
20126
20138
20146
20158
201620
201715
201814
20199
20208
202113
202213
202313
202411


How Colorism Impacts Black Women’s Physical and Mental Health

Literally Hub 6/17/2024

FDA’s Plan to Ban Hair Relaxer Chemical Called Too Little, Too Late

Cancer Health 2/29/2024

FDA Move to Ban Hair Relaxer Chemical Called Too Little, Too Late

California Healthline 2/7/2024

FDA move to ban formaldehyde in hair straighteners called too little, too late

WGBH 2/6/2024

Can using everyday hair care products be harmful to your health?

Yahoo! 12/12/2023

'It's long overdue': Local salons react to FDA proposal to ban hair relaxers

WKBW 12/5/2023

Hair Straighteners and Relaxers May Be Harmful to Health. Here’s How to Make Them Better

Scientific American 11/14/2023

Moderate, Heavy Use of Chemical Hair Relaxer Linked to Uterine Cancer

Health Day 11/2/2023

If You're Using Any ​​of These Toxic Hair Products, Stop Now, FDA Warns`

Best Life 11/1/2023

There’s a straight line between natural-hair discrimination and a higher risk of cancer

MSNBC 11/1/2023

For nearly 30 years, Boston University has led the largest and longest-running study of Black women’s health, shining a light on tragic disparities and showing women their lives matter

BU Today 10/31/2023

If You're Using Any ​​of These Toxic Hair Products, Stop Now, FDA Warns

Best Life 10/31/2023

FDA considers ban on some Black women's hair products that have caused years of harm

ABC News 10/20/2023

FDA is considering a ban on certain hair-straightening chemicals: It would be a ‘win for public health—especially the health of Black women’

Fortune Well 10/19/2023

FDA considering a ban on hair-straightening chemicals. Stylists say Black women have moved on

Los Angeles Times 10/19/2023

: FDA is thinking about a ban on hair-straightening chemicals. Stylists say Black women have moved on

Associated Press 10/19/2023

FDA Proposes Ban on Formaldehyde in Hair Straighteners Over Health Dangers

Physician’s Weekly 10/19/2023

What Black women should know about hair relaxers and their health

NBC News 10/18/2023

FDA Proposes Ban on Formaldehyde in Hair Straighteners Over Health Dangers

U.S. News & World Report 10/18/2023

FDA May Ban Formaldehyde in Hair Straightening Products Over Uterine Cancer Risks

Tech Times 10/18/2023

Another Study Has Linked Chemical Hair Straighteners to Uterine Cancer

POPSUGAR 10/18/2023

What Black women should know about hair relaxers and their health

AOL.com 10/18/2023

FDA plans to propose ban on formaldehyde in hair smoothing, straightening products — here's what to know.

CBS News 10/18/2023

FDA Proposes Ban on Formaldehyde in Hair Straighteners Over Health Dangers

Health Day 10/18/2023

What to Know About the Health Risks of Chemical Hair Straighteners

The New York Times 10/17/2023

FDA proposes ban on hair relaxers with formaldehyde

NBC News 10/17/2023

Use of Hair Relaxers Raises Women's Odds for Uterine Cancer

U.S. News & World Report 10/13/2023

Use of Hair Relaxers Raises Women's Odds for Uterine Cancer

Health Day 10/13/2023

HAIR RELAXERS MAY BOOST BLACK WOMEN’S UTERINE CANCER RISK

Futurity 10/12/2023

Study: Chemical hair relaxers may put Black women at higher risk for uterine cancer

UPI 10/11/2023

BU Study: Long-Term Use Of Chemical Hair Relaxers Linked To Risk Of Cancer

WBZ News Radio 10/11/2023

Yes, some chemicals used in hair products for Black women can lead to breast cancer

KVUE ABC News 7/22/2022

Relaxed Hair Has Made a Comeback on Social Media, Reigniting a Debate on the Straight Style

PopSugar 11/23/2021

Are hair relaxers causing breast cancer in black women?

The Guardian 8/5/2021

Are hair relaxers causing breast cancer in black women? – podcast

The Guardian 8/5/2021

Wellness Wednesday: How To Address Racial Disparities In Breast Cancer

WOSU 7/21/2021

25-year-long study of Black women links frequent use of lye-based hair relaxers to a higher risk of breast cancer

PBS NewsHour 7/14/2021

25-year-long study of Black Women links frequent use of lye-based hair relaxers to a higher risk of breast cancer

The Conversation 7/13/2021

Does Using Hair Relaxers Cause Higher Breast Cancer Risk for Black Women?

BU Today 6/9/2021

Untangling Link Between Hair Relaxers and Breast Cancer Risk in Black Women

Breast Cancer.org 6/8/2021

Moderate Use of Hair Relaxers Won't Raise Black Women's Cancer Risk: Study

Health Day 5/26/2021

Hair Relaxers Won't Raise Black Women's Cancer Risk

WEB MD 5/26/2021
In addition to these self-described keywords below, a list of MeSH based concepts is available here.

Epidemiology
Breast Cancer
Health Disparities
Multiple Myeloma
Monoclonal Gammopathy of Undetermined Significance

I am deeply committed to teaching and mentoring the next generation of research scientists and I am dedicated to promoting an inclusive and supportive scientific and academic environment, where trainees from every background can thrive. In 2022-2023, I participated in the Boston University Provost Mentor Fellows program to strengthen my skills in this area and deepen my mentoring practices. In addition to mentoring students, postdocs, and early career faculty working with the Black Women's Health Study, I am also a senior faculty mentor for the Boston University Chobanian & Avedisian School of Medicine Propelling Rise Of Faculty (PROF) initiative to assist Assistant Professors in reaching their goals for promotion to Associate Professor.

Available to Mentor as: (Review Mentor Role Definitions):
  • Advisor
  • Career Mentor
  • Co-Mentor or Peer Mentor
  • Diversity Mentor
  • Project Mentor
Contact for Mentoring:
  • Email (see 'Contact Info')

72 E. Concord St Instructional (L)
Boston MA 02118
Google Map


Bertrand's Networks
Click the "See All" links for more information and interactive visualizations
Concepts
_
Media Mentions
_
Co-Authors
_
Similar People
_
Same Department